Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)

8 Nov 2017

Abstract excerpt

Metabolic syndrome (MS) is one of the leading risk factors for the development of cardiovascular diseases, type II diabetes mellitus and reproductive system diseases. Currently, not only cardiovascular disease and reproductive history risks related with MS are frequently discussed, but it has been also shown that MS is associated with increased risk of some common cancers (endometrial cancer, postmenopausal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Growth Hormone and Insulin-like Growth Factors
Share to Metabolism, Diabetes, and Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29115033
DOI: 10.1111/ajco.12780

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)PMID 29115033Read ↗

The role of metabolic syndrome variant in the malignant tumors progression.Semantic proximity Read ↗

miRNAs in nutrition, obesity, and cancer: The biology of miRNAs in metabolic disorders and its relationship with cancer developmentSemantic proximity Read ↗

Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping ReviewSemantic proximity Read ↗

Nuclear Receptor RORα/γ: Exciting Modulators in Metabolic Syndrome and Related DisordersSemantic proximity Read ↗

Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control studySemantic proximity Read ↗

A Combined Effect of Expression Levels of Obesity-Related Genes and Clinical Factors on Cancer Survival Rate.Semantic proximity Read ↗

Systemic DNA Damage Response and Metabolic Syndrome as a Premalignant StateSemantic proximity Read ↗

Insight into the Effects of Adipose Tissue Inflammation Factors on miR-378 Expression and the Underlying MechanismSemantic proximity Read ↗

G Protein-Coupled Receptor 75 (GPR75) As a Novel Molecule for Targeted Therapy of Cancer and Metabolic SyndromeSemantic proximity Read ↗

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in CancerSemantic proximity Read ↗

Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and CancerSemantic proximity Read ↗

Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.